Findings published today in Science will accelerate the search for genes involved in human disease. The report provides a first genome-wide view of how the unique composition of genetic variation within each of us leads to unique patterns of gene activity.
People with mesothelioma — a form of cancer associated with asbestos exposure — have a higher survival rate when treated with a combination of two cancer drugs, a large multicenter study finds.
Identifying new medications and providing foolproof cancer diagnosis are two benefits anticipated from research by a team of engineering professors at the University of Houston.
Mater Medical Research Institute director Professor Derek Hart and the team develop the prostate cancer vaccine which appears safe in the first five patients studied in a phase-one trial.
Reuters on monday examined the practice of surrogate motherhood in India, where surrogacy services are “far cheaper than in the West.”
South Dakota businessman Denny Sanford has set a new standard in healthcare philanthropy with an unprecedented gift of $400 million to Sioux Valley Hospitals & Health System.
On a quest to modernize cancer treatment and diagnosis, an MIT professor and her colleagues have created new nanoparticles that mimic blood platelets. The team wants to use these new multifunctional particles to carry out different medical missions inside the body, from imaging to drug delivery.
Instead of dismissing grumblings about being tired or exhausted, people should take these complaints seriously before they lead to a worsened health state or even death, says a University of Alberta researcher investigating fatigue.
Creatine, a popular nutritional supplement used by weightlifters and sprinters to improve athletic performance, could lend muscle strength to people with muscular dystrophies.
Risperidone, a drug used to control schizophrenia symptoms, may also help treat behaviors found in autism spectrum disorder, according to a new review of studies.